Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

RPID Rapid Micro Biosystems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RPID

Price (delayed)

$3.57

Market cap

$156.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.03

Enterprise value

$143.08M

Highlights
The gross profit has soared by 135% year-on-year
RPID's gross margin has soared by 127% year-on-year
RPID's quick ratio is down by 43% year-on-year and by 7% since the previous quarter
Rapid Micro Biosystems's equity has decreased by 38% YoY and by 13% QoQ
Sector: Healthcare
Industry: Diagnostics & Research

Key stats

What are the main financial stats of RPID
Market
Shares outstanding
43.83M
Market cap
$156.48M
Enterprise value
$143.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.36
Price to sales (P/S)
5.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.83
Earnings
Revenue
$29.65M
Gross profit
$1.82M
Operating income
-$47.31M
Net income
-$44.83M
EBIT
-$47.45M
EBITDA
-$42.88M
Free cash flow
-$38.79M
Per share
EPS
-$1.03
EPS diluted
-$1.03
Free cash flow per share
-$0.88
Book value per share
$1.51
Revenue per share
$0.67
TBVPS
$1.94
Balance sheet
Total assets
$85.43M
Total liabilities
$19.94M
Debt
$5.88M
Equity
$65.49M
Working capital
$54.19M
Liquidity
Debt to equity
0.09
Current ratio
4.61
Quick ratio
3.1
Net debt/EBITDA
0.31
Margins
EBITDA margin
-144.7%
Gross margin
6.1%
Net margin
-151.2%
Operating margin
-159.6%
Efficiency
Return on assets
-44.1%
Return on equity
-56.1%
Return on invested capital
-70.2%
Return on capital employed
-67.4%
Return on sales
-160.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RPID stock price

How has the Rapid Micro Biosystems stock price performed over time
Intraday
-4.29%
1 week
9.51%
1 month
51.27%
1 year
376%
YTD
296.67%
QTD
35.23%

Financial performance

How have Rapid Micro Biosystems's revenue and profit performed over time
Revenue
$29.65M
Gross profit
$1.82M
Operating income
-$47.31M
Net income
-$44.83M
Gross margin
6.1%
Net margin
-151.2%
The gross profit has soared by 135% year-on-year
RPID's gross margin has soared by 127% year-on-year
Rapid Micro Biosystems's operating margin has increased by 34% YoY and by 10% QoQ
Rapid Micro Biosystems's net margin has increased by 33% YoY and by 10% from the previous quarter

Price vs fundamentals

How does RPID's price correlate with its fundamentals

Growth

What is Rapid Micro Biosystems's growth rate over time

Valuation

What is Rapid Micro Biosystems stock price valuation
P/E
N/A
P/B
2.36
P/S
5.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.83
Rapid Micro Biosystems's EPS has increased by 15% YoY and by 4.6% from the previous quarter
RPID's P/B is 195% above its last 4 quarters average of 0.8
Rapid Micro Biosystems's equity has decreased by 38% YoY and by 13% QoQ
The P/S is 165% above the last 4 quarters average of 2.0
RPID's revenue is up by 28% YoY and by 6% from the previous quarter

Efficiency

How efficient is Rapid Micro Biosystems business performance
RPID's ROIC is down by 40% year-on-year and by 9% since the previous quarter
Rapid Micro Biosystems's ROS has increased by 34% YoY and by 10% from the previous quarter
The ROE has contracted by 33% YoY and by 8% from the previous quarter
Rapid Micro Biosystems's ROA has decreased by 24% YoY and by 6% from the previous quarter

Dividends

What is RPID's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RPID.

Financial health

How did Rapid Micro Biosystems financials performed over time
RPID's quick ratio is down by 43% year-on-year and by 7% since the previous quarter
The current ratio has contracted by 33% YoY
Rapid Micro Biosystems's debt is 91% less than its equity
Rapid Micro Biosystems's equity has decreased by 38% YoY and by 13% QoQ
The debt to equity has increased by 29% year-on-year and by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.